Gaithersburg’s Novavax says it will have an updated Covid-19 vaccine ready after an FDA committee voted unanimously on the ...
after the COVID-19 vaccine maker struck a licensing deal with Sanofi (SASY.PA) , opens new tab. Under a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70 ...
(Reuters) -Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
after the COVID-19 vaccine maker struck a licensing deal with Sanofi. Under a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70 million at a lofty valuation.
Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing deal with French pharmaceutical giant Sanofi.
Novavax said the licensing agreement allows ... will co-market Novavax's Covid vaccine in most countries starting in 2025. The deal also allows Sanofi to use Novavax's Covid shot and flagship ...
announced a landmark deal with Sanofi where the global pharmaceutical company agreed to co-commercialize Novavax’s Covid-19 vaccine and develop other shots. That agreement, which could be worth ...